生体吸収性スキャフォールド市場規模、シェア、成長分析：材料タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

生体吸収性スキャフォールド市場規模は2023年に17億1,000万米ドルとなり、予測期間（2025-2032年）のCAGRは19.5%で、2024年の20億4,000万米ドルから2032年には85億米ドルに成長する見通しです。

生体吸収性スキャフォールド市場は、技術の進歩と心血管疾患の有病率の上昇によって力強い成長を遂げています。これらの一時的なインプラントは、徐々に溶解することで冠動脈疾患を治療するように設計されており、血管の自然治癒を可能にします。生体適合性の高さからポリマーベースの材料が主流を占めるこの市場は、主に心血管治療における多様な用途にも対応しています。エンドユーザーには、病院、外来手術センター、専門クリニックなどが含まれ、心臓治療入院の増加がその要因となっています。地域別では、先進的なヘルスケアシステムに支えられた北米が市場シェアをリードしており、次いで研究に重点を置く欧州、医療投資と高齢化により成長するアジア太平洋地域が続きます。コストや熟練した専門家の必要性といった課題にもかかわらず、現在進行中の調査は、今後の有望な市場拡大を示唆しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

生体吸収性スキャフォールド市場規模：材料タイプ別& CAGR（2025-2032）

• 市場概要
• ポリマーベーススキャフォールド
• 金属スキャフォールド

生体吸収性スキャフォールド市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 冠動脈疾患
• 末梢動脈疾患

生体吸収性スキャフォールド市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• 心臓カテーテル検査室

生体吸収性スキャフォールド市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• Terumo Corporation（Japan）
• Biotronik SE & Co. KG（Germany）
• REVA Medical, Inc.（USA）
• Elixir Medical Corporation（USA）
• Amaranth Medical, Inc.（USA）
• Arterial Remodeling Technologies（France）
• Meril Life Sciences Pvt. Ltd.（India）
• Kyoto Medical Planning Co., Ltd.（Japan）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• S3V Vascular Technologies（India）
• Zorion Medical（USA）
• ICON Interventional Systems（USA）
• Xenogenics Corporation（USA）
• Arterius Limited（UK）
• SMT（Sahajanand Medical Technologies）（India）
• B. Braun Melsungen AG（Germany）
• Cardionovum GmbH（Germany）

結論と提言

Bioresorbable Scaffolds Market size was valued at USD 1.71 billion in 2023 and is poised to grow from USD 2.04 billion in 2024 to USD 8.5 billion by 2032, growing at a CAGR of 19.5% during the forecast period (2025-2032).

The bioresorbable scaffolds market is experiencing robust growth propelled by technological advancements and a rising prevalence of cardiovascular diseases. These temporary implants, designed to treat coronary artery disease by gradually dissolving, allow for natural vessel healing. Dominated by polymer-based materials due to their biocompatibility, the market also addresses diverse applications, predominantly in cardiovascular treatment. End-users include hospitals, ambulatory surgical centers, and specialized clinics, driven by increased cardiac intervention admissions. Geographically, North America leads in market share, supported by advanced healthcare systems, followed by Europe with its research focus, and a growing Asia-Pacific region due to healthcare investments and an aging demographic. Despite challenges like costs and the need for skilled professionals, ongoing research suggests promising market expansion ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioresorbable Scaffolds Market Segments Analysis

Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioresorbable Scaffolds Market

The rising incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, significantly propels the growth of the bioresorbable scaffolds market. As these health issues become more prevalent, there is an increasing need for advanced therapeutic options that can effectively restore blood flow. This situation fosters a strong demand for innovative medical solutions, such as bioresorbable scaffolds, which offer unique advantages in the treatment of vascular conditions. The ability of these scaffolds to provide temporary support to blood vessels while gradually dissolving is particularly appealing to healthcare providers looking to improve patient outcomes, further driving market expansion.

Restraints in the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market is confronted with a significant obstacle due to the shortage of long-term clinical evidence. There remains a pressing need for comprehensive evaluations of the performance of bioresorbable scaffold implants in comparison to conventional stents. This lack of conclusive data on their efficacy and safety could hinder healthcare professionals from fully embracing these innovative solutions, potentially affecting adoption rates. As a result, the industry must prioritize the generation of robust clinical studies to substantiate the long-term benefits and reliability of bioresorbable scaffolds, ensuring that they can be confidently integrated into patient care practices.

Market Trends of the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market is experiencing a notable surge, primarily driven by the rising geriatric population, which necessitates enhanced healthcare solutions. As the elderly demographic becomes more predominant, their susceptibility to cardiovascular diseases escalates, creating a substantial demand for innovative treatment options. Bioresorbable scaffolds offer a compelling alternative due to their ability to support vascular structures temporarily and then dissolve, eliminating the need for additional surgical interventions. This trend indicates a shift towards patient-centric approaches in cardiology, with healthcare providers increasingly adopting biocompatible materials to improve patient outcomes and overall quality of life in an aging society.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Polymer-based Scaffolds
• Metallic Scaffolds

Global Bioresorbable Scaffolds Market Size by Application & CAGR (2025-2032)

• Market Overview
• Coronary Artery Disease
• Peripheral Artery Disease

Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

Global Bioresorbable Scaffolds Market Size & CAGR (2025-2032)

• North America (Material Type, Application, End-user)
  • US
  • Canada
• Europe (Material Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S3V Vascular Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zorion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenogenics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMT (Sahajanand Medical Technologies) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations